BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1733088)

  • 1. Influence of race on crossmatch outcome and recipient eligibility for transplantation.
    Kerman RH; Kimball PM; Van Buren CT; Lewis RM; Cavazos D; Heydari A; Kahan BD
    Transplantation; 1992 Jan; 53(1):64-7. PubMed ID: 1733088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of HLA frequency differences in races on the access to optimally HLA-matched cadaver renal transplants. The Medical Advisory Committee.
    Lazda VA
    Transplantation; 1992 Feb; 53(2):352-7. PubMed ID: 1738929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients.
    Kerman RH; Kimball PM; Van Buren CT; Lewis RM; Kahan BD
    Transplantation; 1991 Feb; 51(2):338-42. PubMed ID: 1825242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1996; ():1-14. PubMed ID: 9286555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual crossmatch in kidney transplantation.
    Piazza A; Ozzella G; Poggi E; Caputo D; Manfreda A; Adorno D
    Transplant Proc; 2014 Sep; 46(7):2195-8. PubMed ID: 25242749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful transplantation of cyclosporine-treated allograft recipients with serologically positive historical, but negative preoperative, donor crossmatches.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
    Transplantation; 1985 Dec; 40(6):615-9. PubMed ID: 3907031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the UNOS mandatory sharing policy on recipients of the black and white races--experience at a single renal transplant center.
    Barger B; Shroyer TW; Hudson SL; Deierhoi MH; Barber WH; Curtis JJ; Phillips MG; Julian BA; Gaston RS; Laskow DA
    Transplantation; 1992 Apr; 53(4):770-4. PubMed ID: 1566342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival.
    Koyama H; Cecka JM; Terasaki PI
    Transplantation; 1994 Apr; 57(7):1064-8. PubMed ID: 8165704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney and pancreas transplantation without a crossmatch in select circumstances--it can be done.
    Matas AJ; Humar A; Kandaswamy R; Payne WD; Gruessner RW; Sutherland DE
    Clin Transplant; 2001 Aug; 15(4):236-9. PubMed ID: 11683816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors.
    Butkus DE; Meydrech EF; Raju SS
    N Engl J Med; 1992 Sep; 327(12):840-5. PubMed ID: 1508243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of gender and access to cadaveric renal transplantation.
    Bloembergen WE; Mauger EA; Wolfe RA; Port FK
    Am J Kidney Dis; 1997 Dec; 30(6):733-8. PubMed ID: 9398115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The virtual crossmatch--a screening tool for sensitized pediatric heart transplant recipients.
    Zangwill SD; Ellis TM; Zlotocha J; Jaquiss RD; Tweddell JS; Mussatto KA; Berger S
    Pediatr Transplant; 2006 Feb; 10(1):38-41. PubMed ID: 16499585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survival.
    Kerman RH; Kimball PM; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Heydari A; Kahan BD
    Transplantation; 1991 Feb; 51(2):316-20. PubMed ID: 1994522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined liver-kidney transplantation with positive crossmatch: Role of delayed kidney transplantation.
    Goggins WC; Ekser B; Rokop Z; Lutz AJ; Mihaylov P; Mangus RS; Fridell JA; Powelson JA; Kubal CA
    Surgery; 2021 Oct; 170(4):1240-1247. PubMed ID: 34092375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship among donor-recipient HLA mismatches, rejection, and death from coronary artery disease in cardiac transplant recipients.
    Kerman RH; Kimball P; Scheinen S; Radovancevic B; Van Buren CT; Kahan BD; Frazier OH
    Transplantation; 1994 Mar; 57(6):884-8. PubMed ID: 8154036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of panel-reactive antibody levels in Caucasian and African American renal transplant candidates.
    Cooper TY; Jordan CL; Willimon CM; Land GA
    Transplantation; 1995 Aug; 60(4):327-30. PubMed ID: 7652759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients.
    Kerman RH; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Gerolami K; Kahan BD
    Transplantation; 1990 Jan; 49(1):52-6. PubMed ID: 2301027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine.
    Kerman RH; van Buren CT; Lewis RM; Frazier OH; Cooley D; Kahan BD
    Transplantation; 1988 Feb; 45(2):333-7. PubMed ID: 3278425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Pretransplant Donor-Specific Alloantibodies With Different Crossmatch Techniques.
    Moszkowska G; Zieliński M; Zielińska H; Dukat-Mazurek A; Dębska-Zielkowska J; Dębska-Ślizień A; Rutkowski B; Trzonkowski P
    Transplant Proc; 2018; 50(6):1625-1630. PubMed ID: 30056871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial differences in access to the kidney transplant waiting list for children and adolescents with end-stage renal disease.
    Furth SL; Garg PP; Neu AM; Hwang W; Fivush BA; Powe NR
    Pediatrics; 2000 Oct; 106(4):756-61. PubMed ID: 11015519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.